Brege Laura Insider Trades

Insider Trading History

Track insider trading activity for Brege Laura. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $504k 23,202 shares
Last Trade
May 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 8,107 shares
$21.66
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 8,107 shares
$21.66
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $348k 16,004 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$548k 25,315 shares
$21.66
$21.72
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $1.59M 17,194 shares
Last Trade
Sep 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.26M 17,000 shares
$74.40
$92.49
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $3.02M 32,703 shares
Last Trade
Sep 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.29M 17,000 shares
$75.99
$92.49
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $0 0 shares
Last Trade
Sep 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.29M 17,000 shares
$75.99
$92.49
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Director
Holding Value $1.12M 30,000 shares
Last Trade
Jun 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$440k 30,000 shares
$14.68
$37.23
Pacira BioSciences
Pacira BioSciences PCRX
Director
Holding Value $538k 23,715 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 11,279 shares
$24.34
$22.67
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $328k 15,095 shares
Last Trade
Jun 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$315k 14,446 shares
$21.78
$21.72
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $0 0 shares
Last Trade
May 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$251k 5,703 shares
$44.00
$92.49
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $300k 13,793 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 13,793 shares
$22.29
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $642k 29,541 shares
Last Trade
May 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 9,387 shares
$22.29
$21.72
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 9,387 shares
$22.29
$21.72
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $580k 6,268 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$276k 6,268 shares
$44.00
$92.49
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $1.45M 15,703 shares
Last Trade
May 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$251k 5,703 shares
$44.00
$92.49
Pacira BioSciences
Pacira BioSciences PCRX
Director
Holding Value $398k 17,552 shares
Last Trade
Aug 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.8k 1,000 shares
$12.81
$22.67
Pacira BioSciences
Pacira BioSciences PCRX
Director
Holding Value $375k 16,552 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$349k 12,179 shares
$28.68
$22.67
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Director
Holding Value $767k 20,594 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 20,594 shares
$17.13
$37.23
Mirum Pharmaceuticals
Mirum Pharmaceuticals MIRM
Director
Holding Value $812k 8,779 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 8,779 shares
$26.30
$92.49
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$97.3k 6,652 shares
$14.62
$21.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up